Category Archives: IoT

woman with fitbit

How the Internet of Medical Things (IoMT) Supports Improved Patient Outcomes

Webinar Recording Available On-Demand

By: Sandra K. Rodriguez, Market Analyst, Axendia

The Internet of Medical Things (IoMT) and the transition to outcomes based reimbursements are changing the way medical device companies approach new product development. IoMT and connected healthcare can enable the transition to patient-centered, preventative care.  IoMT connected devices are going to play an important role in supporting improved quality of care, patient outcomes, and also improving the business of healthcare in the outcome economy.  Yet with smart, connected products comes a new level of complexity throughout the total product lifecycle

In a recent FDANews webinar, I was joined by David Wolf and Jordan Reynolds, both Senior Managers with Kalypso.  We discussed the impact the increased number of connected IoMT devices is having on outcome based healthcare models, the potential benefits and pitfalls, and how to best leverage PLM solutions and IoT in a changing healthcare environment. Continue reading

2017 Year end review

Award Winning Year for Axendia – Looking at the 2018 Crystal Ball

By Daniel R. Matlis

2017 has been an exceptional year for Axendia.  We were recognized by CIOReview magazine as one of the 20 Most Promising Pharma and Life Sciences Solution Providers.  We also had the opportunity to address audiences around the globe, including Asia, Europe, North and South America.

Our analysts had the privilege to provide insight and trusted advice to leaders across the Life Science and Healthcare ecosystems including executives in industry, technology & service providers as well as policy makers and regulators.
In the last year we advised our clients on critical topics such as:


New Versions of Everything, New Expectations

Realizing the Digital Twin – 2017 Siemens Analyst Conference

By:  Sandra K. Rodriguez, Market Analyst

The Siemens Analyst Conference took place in Boston from September 6 – 7, 2017.  Dr. Jan Mrosik, CEO Siemens Digital Factory Division, opened the conference with a clear message:

“Digitalization changes everything and a common digital thread enables continuous business transformation!”

Siemens has invested $6.5B since 2013 in its digital enterprise suite, beginning with the acquisition of LMS International which expanded its strategy for system validation and verification.  The company is also seeking to establish a leadership role in electronics and semiconductor product and process simulation by adding Mentor Graphics to its Digital Factory division.

A Digital Twin is not a concept, it is a disruptive technology.  It enables companies to competitively change the way products are realized, come to life and evolve.  Adding digital twin technology within a smart factory offers companies three unique benefits:

  • The ability to predict profitability through analysis of production scenarios
  • Improved efficiencies through the digital thread and virtual commissioning
  • Optimized production through the comparison of real and digital production systems

Continue reading

cyber security copy

FDA confirms: Hacking a pacemaker only requires commercially available equipment

By: Giselle C. Matlis, Research Assistant

On August 29, 2017 the FDA published a Safety Communication, Firmware Update to Address Cybersecurity Vulnerabilities Identified in Abbott’s (formerly St. Jude Medical’s) Implantable Cardiac Pacemakers , where they announced that they have reviewed information concerning potential cybersecurity vulnerabilities associated with implantable cardiac pacemakers.cyber security copy

In its Safety Communication, FDA confirmed that if exploited, these vulnerabilities could allow an unauthorized user with commercially available equipment to access a patient’s device and could be used to modify programming commands to the implanted pacemaker.  This could result in patient harm from rapid battery depletion or administration of inappropriate pacing. At this point, there have been no known patient harm, however, the FDA has approved a firmware update that addresses these cybersecurity vulnerabilities and reduces the risk of exploitation and subsequent patient harm.

In fact, former Vice President Dick Cheney discussed his fears that terrorists could hack into his pacemaker, a fear he saw come to life while watching an episode of “Homeland.”Indeed, when doctors implanted Cheney’s pacemaker in 2007, they disabled the wireless feature out of fear that someone could manipulate it and disrupt his heartbeat.

The FDA has been warning about cybersecurity on medical devices for over a decade.  As Eric Luyer stated in his March 2017 article “the time to implement a proactive, comprehensive risk management program to eliminate cybersecurity threats is now”.

Cybersecurity of connected medical devices must be a key step in the design process.  Medical Device manufacturers must be proactive instead of reactive to cybersecurity concerns when developing new products.


Medical Device Industry Survey

Do Medical Device Manufacturers Have a Culture of Innovation and Quality?

Help Us Find Out!

Flat line alert on a heart monitor - 3d render on detail pixellated screeen

  • Are you Manufacturing Innovative Medical Devices?
  • Is your company building a culture of innovation and quality?
  • How do your actions compare with your peers?

To find answers to these and other questions of interest to the medical device community, we are asking for your participation in this global research study.

The survey also seeks to understand:

  • What practical steps medical manufacturers are taking to evolve their quality practices
  • The role of automation in supporting best practices for compliance and quality
  • How manufacturers are incorporating smart, connected sensors across their product portfolio
  • The impact of the Internet of Things (IoT) on medical device manufacturers

As a survey participant, you may register to receive a complimentary copy of the research report.  Please Note: All individuals responses will be kept strictly confidential and only aggregated data will be used.

Follow this link to begin the survey.

This primary research is being conducted by Axendia and sponsored by PTC.